AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24267042 — intervention group
Group type: COMPARATOR
Intervention: Control protein and placebo tablets
Number of subjects: 131
Study 24267042 — intervention group
Group type: EXPERIMENTAL
Intervention: Equol producers
Number of subjects: 131
Study 21787431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) combined with medication (CBT/MED)
Number of subjects: 54
Study 21787431 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) combined with medication (TAU/MED)
Number of subjects: 54
Study 19347683 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia care consultation intervention provided by dementia care consultants at an Alzheimer's association chapter over a 12-month period
Number of subjects: 84
Study 19347683 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia care consultation intervention
Number of subjects: 84
Study 19347683 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving educational and community resource information without care consultation
Number of subjects: 84
Study 17943674 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-compression therapy (VCT) in addition to conventional therapy for 10 sessions
Number of subjects: 18
Study 17943674 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy only
Number of subjects: 18
Study 17943674 — intervention group
Group type: COMPARATOR
Intervention: Comparison of VCT with conventional therapy
Number of subjects: 18
Study 15476447 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I plus pretreatment with methimazole (30 mg/day)
Number of subjects: 61
Study 15476447 — intervention group
Group type: COMPARATOR
Intervention: 131I alone
Number of subjects: 61
Study 11546896 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging in CADASIL patients
Number of subjects: 20
Study 11546896 — intervention group
Group type: COMPARATOR
Intervention: Diffusion tensor imaging in controls
Number of subjects: 20
Study 11546896 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis in CADASIL patients
Number of subjects: 20
Study 9602987 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesicular solution of 1.50 mg PGE2 (2 x 0.75 mg)
Number of subjects: 110
Study 9602987 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis for urinary retention (Control)
Number of subjects: 110
Study 7802235 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50
Study 7802235 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 50
Study 3341246 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin and mineral supplement for 3 months
Number of subjects: 0
Study 31432392 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous posaconazole 300 mg (fasted)
Number of subjects: 18
Study 31432392 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral posaconazole 300 mg (fasted)
Number of subjects: 18
Study 31432392 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral posaconazole 300 mg (high-fat breakfast)
Number of subjects: 18
Study 31432392 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events for intravenous posaconazole 300 mg
Number of subjects: 18
Study 31432392 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events for oral posaconazole 300 mg (high-fat breakfast)
Number of subjects: 18
Study 28592386 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P6
Number of subjects: 549
Study 28592386 — intervention group
Group type: COMPARATOR
Intervention: Reference trastuzumab
Number of subjects: 549
Study 26072311 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence therapy (AT) plus usual care
Number of subjects: 114
Study 26072311 — intervention group
Group type: COMPARATOR
Intervention: Usual psychiatric care
Number of subjects: 114
Study 23452682 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly assigned 14-month treatments for ADHD (specific treatments not detailed in the abstract)
Number of subjects: 436
Study 23452682 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication at follow-up (mostly stimulants)
Number of subjects: 436
Study 23452682 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative stimulant treatment over time
Number of subjects: 436
Study 23452682 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD sample
Number of subjects: 436
Study 23452682 — intervention group
Group type: COMPARATOR
Intervention: Non-ADHD sample
Number of subjects: 436
Study 22035534 — intervention group
Group type: EXPERIMENTAL
Intervention: Control Preferences Scale
Number of subjects: 0
Study 22035534 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision making
Number of subjects: 0
Study 19745648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifuga racemosa (black cohosh) extract
Number of subjects: 28
Study 19745648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 17261982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation period > 24 hrs (group I)
Number of subjects: 237
Study 17261982 — intervention group
Group type: COMPARATOR
Intervention: Intubation period < 24 hrs (group II)
Number of subjects: 237
Study 14500073 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine (1 microg/kg per min)
Number of subjects: 26
Study 14500073 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 26
Study 10718230 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse requested x rays
Number of subjects: 675
Study 10718230 — intervention group
Group type: COMPARATOR
Intervention: Control group (doctors or ENPs requesting x rays)
Number of subjects: 675
Study 9379368 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 40
Study 9379368 — intervention group
Group type: COMPARATOR
Intervention: ECCE
Number of subjects: 40
Study 9379368 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 1316885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovasoprotective (CVP) diet (group A)
Number of subjects: 621
Study 1316885 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (group B)
Number of subjects: 621
Study 3707286 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (5 or 10 mg)
Number of subjects: 0
Study 3707286 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine (5 mg)
Number of subjects: 0
Study 3707286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3707286 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective effects of diazepam
Number of subjects: 0
Study 29433506 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm with access to the app plus intervention messages
Number of subjects: 573
Study 29433506 — intervention group
Group type: COMPARATOR
Intervention: Control arm with access to the app plus control messages
Number of subjects: 573
Study 29433506 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 573
Study 25567541 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracongruent (UC) TKA
Number of subjects: 90
Study 25567541 — intervention group
Group type: COMPARATOR
Intervention: Posterior stabilized (PS) TKA
Number of subjects: 90
Study 24919727 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 1g/kg
Number of subjects: 53
Study 24919727 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (Control)
Number of subjects: 53
Study 22302818 — intervention group
Group type: EXPERIMENTAL
Intervention: Isochronous auditory rhythm
Number of subjects: 12
Study 20108040 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistin
Number of subjects: 32
Study 20108040 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-18
Number of subjects: 32
Study 20108040 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin
Number of subjects: 32
Study 20108040 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) correlation with resistin
Number of subjects: 32
Study 20108040 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) correlation with IL-18
Number of subjects: 32
Study 19065416 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannula method (group 1)
Number of subjects: 30
Study 19065416 — intervention group
Group type: EXPERIMENTAL
Intervention: Smith and Nozik method (group 2)
Number of subjects: 30
Study 19065416 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital floor injection method (group 3)
Number of subjects: 30
Study 16048152 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (0.2 mg/kg)
Number of subjects: 23
Study 16048152 — intervention group
Group type: COMPARATOR
Intervention: Intranasal midazolam (0.2 mg/kg)
Number of subjects: 23
Study 12525336 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsatisfactory primary care (less than 60% compliance to recommendations)
Number of subjects: 258
Study 12525336 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsatisfactory primary care
Number of subjects: 258
Study 12525336 — intervention group
Group type: EXPERIMENTAL
Intervention: Less than 2 visits to family physician during the last year
Number of subjects: 258
Study 12525336 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose level
Number of subjects: 258
Study 12525336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive level
Number of subjects: 258
Study 10584045 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA diets (olive oil, peanut oil, peanuts and peanut butter)
Number of subjects: 22
Study 10584045 — intervention group
Group type: COMPARATOR
Intervention: Step II diet
Number of subjects: 22
Study 10584045 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA diets
Number of subjects: 22
Study 10584045 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA diets (OO, PO, PPB)
Number of subjects: 22
Study 8714171 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of intravenous piracetam (12 g in 250 ml of saline)
Number of subjects: 11
Study 8714171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1825100 — intervention group
Group type: EXPERIMENTAL
Intervention: AA-2414 (40 mg/day)
Number of subjects: 15
Study 1825100 — intervention group
Group type: EXPERIMENTAL
Intervention: AA-2414 (20 mg/day)
Number of subjects: 15
Study 7028822 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersalloy
Number of subjects: 0
Study 7028822 — intervention group
Group type: COMPARATOR
Intervention: Oraloy, Sybraloy, Tytin
Number of subjects: 0
Study 7028822 — intervention group
Group type: COMPARATOR
Intervention: Aristaloy
Number of subjects: 0
Study 7028822 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersalloy, Sybraloy
Number of subjects: 0
Study 30012907 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslipidemia assessment through biochemical tests
Number of subjects: 2184
Study 29896813 — intervention group
Group type: EXPERIMENTAL
Intervention: Respirator Intervention Phase (RIP)
Number of subjects: 40
Study 29896813 — intervention group
Group type: EXPERIMENTAL
Intervention: Headphone Intervention Phase (HIP)
Number of subjects: 40
Study 29896813 — intervention group
Group type: EXPERIMENTAL
Intervention: Respirator plus Headphone Intervention Phase (RHIP)
Number of subjects: 40
Study 29896813 — intervention group
Group type: COMPARATOR
Intervention: No Intervention Phase (NIP)
Number of subjects: 40
Study 27289122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic treatment
Number of subjects: 1310
Study 27289122 — intervention group
Group type: COMPARATOR
Intervention: Standard glycemic treatment
Number of subjects: 1310
Study 27289122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment
Number of subjects: 1310
Study 27289122 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure treatment
Number of subjects: 1310
Study 27289122 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 1310
Study 27289122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1310
Study 25196855 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatments
Number of subjects: 961
Study 25196855 — intervention group
Group type: COMPARATOR
Intervention: Non-complete remission (CR) status at HSCT
Number of subjects: 961
Study 25196855 — intervention group
Group type: COMPARATOR
Intervention: Non-chronic graft-versus-host disease after HSCT
Number of subjects: 961
Study 25196855 — intervention group
Group type: COMPARATOR
Intervention: Multifocal involvement at EMR
Number of subjects: 961
Study 25196855 — intervention group
Group type: COMPARATOR
Intervention: Non-CR after EMR treatments
Number of subjects: 961
Study 25196855 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft-versus-leukemia effect
Number of subjects: 961
Study 22089534 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine alone
Number of subjects: 279
Study 22089534 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic
Number of subjects: 279
Study 22089534 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker
Number of subjects: 279
Study 22089534 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor/angiotensin II receptor antagonist
Number of subjects: 279
Study 20435205 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (20 mg)
Number of subjects: 58
Study 20435205 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg) plus Ezetimibe (10 mg)
Number of subjects: 58
Study 20435205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 17368974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 0
Study 17368974 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestrogen only treatment
Number of subjects: 0
Study 15755281 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex vivo chemosensitivity testing using the chemosensitivity index (C(i))
Number of subjects: 0
Study 15755281 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemosensitivity index (C(i))
Number of subjects: 0
Study 12072679 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal catheter replacement when clinically indicated (group II)
Number of subjects: 43
Study 12072679 — intervention group
Group type: COMPARATOR
Intervention: Routine catheter replacement every 5 days (group I)
Number of subjects: 43
Study 10485423 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic protein treated oxygenators
Number of subjects: 58
Study 10485423 — intervention group
Group type: COMPARATOR
Intervention: Heparin coated circuits
Number of subjects: 58
Study 8636371 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND) 300 mg/week
Number of subjects: 11
Study 8636371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 8636371 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (TE) 300 mg/week
Number of subjects: 11
Study 1780961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted (F)
Number of subjects: 8
Study 1780961 — intervention group
Group type: COMPARATOR
Intervention: Standard Breakfast (SB)
Number of subjects: 8
Study 1780961 — intervention group
Group type: COMPARATOR
Intervention: Bolus of Enteral Nutrients (EB)
Number of subjects: 8
Study 1780961 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow Infusion of Enteral Nutrients (EI)
Number of subjects: 8
Study 7317698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 64
Study 7317698 — intervention group
Group type: COMPARATOR
Intervention: Antidepressants
Number of subjects: 64
Study 7317698 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cognitive therapy and antidepressants
Number of subjects: 64
Study 31678438 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Conductivity Device (ECD)
Number of subjects: 61
Study 31678438 — intervention group
Group type: COMPARATOR
Intervention: Conventional trocar
Number of subjects: 61
Study 31621673 — intervention group
Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia
Number of subjects: 52
Study 31621673 — intervention group
Group type: COMPARATOR
Intervention: Mid thoracic epidural anesthesia
Number of subjects: 52
Study 28483786 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster aspart
Number of subjects: 689
Study 28483786 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 689
Study 26100584 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS)
Number of subjects: 563
Study 26100584 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 563
Study 23411993 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsion eye drop (containing emulsified castor oil), dosed four times per day for 7 days
Number of subjects: 20
Study 23411993 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsion eye drop (containing emulsified castor oil)
Number of subjects: 20
Study 23411993 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 20
Study 23411993 — intervention group
Group type: COMPARATOR
Intervention: Dry eye subjects
Number of subjects: 20
Study 22514897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nail with reaming (group A)
Number of subjects: 60
Study 22514897 — intervention group
Group type: COMPARATOR
Intervention: Intramedullary nail without reaming (group B)
Number of subjects: 60
Study 19176724 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety of LED foods
Number of subjects: 84
Study 19176724 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety of HED foods
Number of subjects: 84
Study 19176724 — intervention group
Group type: COMPARATOR
Intervention: Same HED foods
Number of subjects: 84
Study 19176724 — intervention group
Group type: COMPARATOR
Intervention: Same foods
Number of subjects: 84
Study 19176724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitized children
Number of subjects: 84
Study 19176724 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety of foods
Number of subjects: 84
Study 19176724 — intervention group
Group type: EXPERIMENTAL
Intervention: LED foods
Number of subjects: 84
Study 17573736 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-eclampsia in index pregnancy
Number of subjects: 1515
Study 17573736 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational hypertension in index pregnancy
Number of subjects: 1515
Study 17573736 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparous women with gestational hypertension
Number of subjects: 1515
Study 17573736 — intervention group
Group type: COMPARATOR
Intervention: Normal index pregnancy
Number of subjects: 1515
Study 17573736 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive index pregnancy
Number of subjects: 1515
Study 10971232 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 100 mg twice daily
Number of subjects: 199
Study 10971232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 8795328 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lignocaine spray (40 mg)
Number of subjects: 90
Study 8795328 — intervention group
Group type: COMPARATOR
Intervention: Intravenous lignocaine 0.5 mg.kg‐1
Number of subjects: 90
Study 8795328 — intervention group
Group type: COMPARATOR
Intervention: Intravenous lignocaine 1.5 mg.kg‐1
Number of subjects: 90
Study 1506123 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 5 mg/kg
Number of subjects: 56
Study 1506123 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg/kg
Number of subjects: 56
Study 1506123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 6734051 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.05, 0.1, and 0.2 mg/kg)
Number of subjects: 8
Study 6734051 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (0.1, 0.2, and 0.4 mg/kg)
Number of subjects: 8
Study 6734051 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 8
Study 31490959 — intervention group
Group type: COMPARATOR
Intervention: LPV/r+3TC (dual therapy)
Number of subjects: 172
Study 31490959 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r+2NRTIs (triple therapy)
Number of subjects: 172
Study 31490959 — intervention group
Group type: EXPERIMENTAL
Intervention: Virologic suppression
Number of subjects: 172
Study 29297472 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid treatment (minimally invasive direct coronary artery bypass / percutaneous coronary intervention)
Number of subjects: 200
Study 29297472 — intervention group
Group type: COMPARATOR
Intervention: Classic treatment (coronary artery bypass grafting / off‑pump coronary artery bypass)
Number of subjects: 200
Study 29297472 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid treatment
Number of subjects: 200
Study 27141838 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (larger LPPs to pleasant pictures)
Number of subjects: 45
Study 27141838 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (smaller LPPs to pleasant pictures)
Number of subjects: 45
Study 24029429 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized dosing of ESA guided by the Smart Anemia Manager algorithm
Number of subjects: 62
Study 24029429 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol for ESA dosing
Number of subjects: 62
Study 24029429 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized dosing of ESA
Number of subjects: 62
Study 22488277 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated, full‐length Quick Comfort Insoles
Number of subjects: 40
Study 22488277 — intervention group
Group type: COMPARATOR
Intervention: Control group (athletic shoes without orthotics)
Number of subjects: 40
Study 21313901 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrullus colocynthis (300 mg daily for 6 weeks)
Number of subjects: 100
Study 21313901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 17512246 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP-pretreated group
Number of subjects: 140
Study 17512246 — intervention group
Group type: COMPARATOR
Intervention: Non-CPAP-pretreated group
Number of subjects: 140
Study 16062095 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 66
Study 16062095 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 66
Study 16062095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66